Glenmark Therapeutics Inc., USA (Glenmark) is pleased to announce the launch1 of Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2% (OTC); compared to the active ingredient in Pataday®2 Once ...

LONDON, GREATER LONDON, UNITED KINGDOM, July 7, 2025 /EINPresswire.com/ -- Save 30% On All Global Market Reports With Code ONLINE30 – Stay Informed On Tariff Changes, Macroeconomic Trends, And More.

Allergic rhinitis affects between 15% and 20% of the population, and seasonal exacerbations account for significant morbidity in spring and summer.

In one randomized, double-masked clinical trial olopatadine 0.1% solution (Patanol ®, Alcon, Ft. Worth, TX) was superior to cromolyn in reducing itching and redness and appeared to have better ...

Alembic Pharmaceuticals - Read all the latest news headline updates on Alembic Pharmaceuticals. Get all the Alembic Pharmaceuticals breaking news updates, videos, photostories and more at Business ...

Glenmark Pharmaceuticals Ltd News: Get the latest news today on Glenmark Pharmaceuticals Ltd. Follow Business Standard for the complete news coverage and key information about the Glenmark ...